Overexpression of the recently identified oncogene REDD1 correlates with tumor progression and is an independent unfavorable prognostic factor for ovarian carcinoma

Table 5 Cytoplasmic REDD1 expression and DFS

REDD1 expression	No. of patients	Median survival months (95% CI)	Survival rate (95% CI)			χ ²	P-value
REDD1 expression	No. of patients	Median survival months (95% CI)	36-months	60-months	120-months	χ ²	P-value
Low expression	148	103.200(76.880,129.520)	0.76(0.671,0.828)	0.60(0.495,0.690)	0.27(0.161,0.391)	60.873	< 0.001
High expression	81	20.000(15.954,24.046)	0.41(0.292,0.524)	0	0

ISSN: 1746-1596